Zai Lab (ZLAB) Asset Writedowns and Impairment (2020 - 2026)

Zai Lab's (ZLAB) quarterly Asset Writedowns and Impairment came in at -$15000.0 in Q1 2026, down 155.56% year-on-year from $27000.0 in Q1 2025, and down 100.13% quarter-over-quarter from $11.4 million in Q4 2025.

Zai Lab (ZLAB) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

Zai Lab has disclosed Asset Writedowns and Impairment across 7 years of filings, most recently posting -$15000.0 for Q1 2026.

  • Asset Writedowns and Impairment for Q1 2026 came in at -$15000.0, down 155.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 million (up 1356.12% YoY), and the FY2025 annual result was $12.3 million, up 1407.73% from the prior year.
  • Asset Writedowns and Impairment came in at -$15000.0 for Q1 2026 at Zai Lab, down from $11.4 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $11.4 million in Q4 2025 to a low of -$759000.0 in Q3 2024.
  • The 5-year median for Asset Writedowns and Impairment is $2500.0 (2022), against an average of $821562.5.
  • Across the five-year window, Asset Writedowns and Impairment plunged 23066.67% in 2023 and soared 37650.0% in 2024, its largest moves.
  • Zai Lab's Asset Writedowns and Impairment stood at $3000.0 in 2022, then slumped by 23066.67% to -$689000.0 in 2023, then soared by 218.72% to $818000.0 in 2024, then soared by 1289.85% to $11.4 million in 2025, then sank by 100.13% to -$15000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at -$15000.0 (Q1 2026), $11.4 million (Q4 2025), and $918000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15,000.00
Mar 31, 2026 -15,000.00
Dec 31, 2025 11.37 Mn
Dec 31, 2025 11.37 Mn
Sep 30, 2025 918,000.00
Sep 30, 2025 918,000.00
Jun 30, 2025 -26,000.00
Jun 30, 2025 -26,000.00
Mar 31, 2025 27,000.00
Mar 31, 2025 27,000.00
Dec 31, 2024 818,000.00
Dec 31, 2024 818,000.00
Sep 30, 2024 -759,000.00
Sep 30, 2024 -759,000.00
Jun 30, 2024 755,000.00
Jun 30, 2024 755,000.00
Mar 31, 2024 1,000.00
Mar 31, 2024 1,000.00
Dec 31, 2023 -689,000.00
Dec 31, 2023 -689,000.00